EIF1A depletion restrains human pituitary adenoma progression
EIF1A encodes a translation initiation factor in eukaryocyte and aberrant expression of EIF1A is deemed to be associated with dysfunctions in intracranial diseases. The goal of this research was to explore the impacts of EIF1A on progression of human pituitary adenoma (PA). We employed immunohistoch...
Guardado en:
Autores principales: | Rongxin Geng, Xiaonan Zhu, Xiang Tao, Junhui Liu, Haitao Xu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e478b3169a6f4665b81d33912ebe153e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Tumor-Associated Macrophages: New Horizons for Pituitary Adenoma Researches
por: Changxi Han, et al.
Publicado: (2021) -
Anti-VEGF Therapy in Refractory Pituitary Adenomas and Pituitary Carcinomas: A Review
por: Congxin Dai, et al.
Publicado: (2021) -
Treatment of Aggressive Pituitary Adenomas: A Case-Based Narrative Review
por: Odelia Cooper, et al.
Publicado: (2021) -
Baseline MRI findings as predictors of hypopituitarism in patients with non-functioning pituitary adenomas
por: Reem Al Argan, et al.
Publicado: (2021) -
Comparative evaluation of several parameters of glycemic homeostasis in patients with functional pituitary adenomas
por: Rostislavovna Mikityuk, et al.
Publicado: (2014)